KRAS and familial pancreatic carcinoma: In fact, Konkimalla group reported for the first time the ability of this class of compounds to accumulate, increase granularity, and induce cell death via autophagy of an apoptosis-resistant and KRAS and p53 mutated pancreatic cancer cell line [32].